Physician profile
Craig Levitz
NPI 1942209507
$40,358.15
in general payments reported to CMS, 2019-2025
19 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,207 · 2020: $5,072 · 2021: $20K · 2022: $4,696 · 2023: $6,287 · 2024: $994 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,850 · Food and Beverage: $1,440 · Travel and Lodging: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,850.00 |
| Food and Beverage | $1,440.09 |
| Travel and Lodging | $302.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16,514.02 | 2020-2025 | |
| Depuy Synthes Products, INC. | $9,998.00 | 2021-2023 | |
| Depuy Synthes Sales INC. | $6,115.91 | 2021-2023 | Orthovisc, Monovisc |
| Arthrex, INC. | $2,585.82 | 2019-2025 | Arthrex |
| Gotham Surgical Solutions & Devices, INC. | $1,858.00 | 2019-2021 | |
| Stryker Corporation | $1,382.57 | 2019-2024 | Inspace, Mako, Triathlon |
| Medical Device Business Services, INC. | $645.16 | 2019-2021 | |
| Polaris Technology Solutions LLC | $304.47 | 2023-2025 | |
| Triad Life Sciences INC. | $155.89 | 2022 | |
| Horizon Therapeutics Plc | $142.77 | 2019 | |
| Acera Surgical, INC. | $139.40 | 2024 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $114.01 | 2021 | |
| Djo, LLC | $103.81 | 2021 | |
| Maruho Medical, INC. | $98.23 | 2019 | |
| Pacira Therapeutics, INC. | $78.15 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $69.80 | 2022 | |
| Pfizer INC. | $27.59 | 2020 | |
| Zimmer Biomet Holdings, INC. | $24.55 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$132.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Levitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.